logo
logo
Sign in

Yeast Infection Treatment Market Size, In-Depth Analysis Report And Global Forecast To 2033

avatar
rama
Yeast Infection Treatment Market Size, In-Depth Analysis Report And Global Forecast To 2033

Overview and Scope

Yeast infection treatment is a medication employed to address and resolve infections caused by the overgrowth of the Candida fungus, commonly known as a yeast infection. These infections, known as candidiasis or yeast infections, can occur in various parts of the body, including the mouth (oral thrush), genitals (vaginal yeast infection), skin, and other mucous. They are used to relieve the symptoms of a yeast infection.

Sizing and Forecast

The yeast infection treatment market size has grown strongly in recent years. It will grow from $4.02 billion in 2023 to $4.33 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased prevalence of yeast infections, growing awareness about fungal infections, aging population, rise in healthcare expenditure globally, and development and approval of new antifungal medications.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Segmentation & Regional Insights

The yeast infection treatment market covered in this report is segmented –

1) By Type: Powders, Creams Or Ointments, Tablets Or Capsules, Other Types

2) By Treatment: Medical Treatment, Surgery

3) By Indication: Genital Candidiasis, Invasive Candidiasis, Oropharyngeal Or Esophageal Candidiasis (Thrush), Other Indications

4) By Route Of Administration: Oral, Topical, IV (Intravenous) Or IM (Intramuscular), Other Routes Of Administration

5) By Application: Retail Pharmacies Or Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, Other Applications

North America was the largest region in the yeast infection treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yeast infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13958&type=smp

Major Driver Impacting Market Growth

The rise in the prevalence of autoimmune disease is expected to propel the growth of the yeast infection treatment market going forward. Autoimmune disease is a condition where the immune system mistakenly attacks healthy cells, tissues, and organs, weakening bodily function and potentially becoming life-threatening. Yeast infection treatment are used in managing and preventing the complications of autoimmune disease by addressing recurrent yeast infections, which are linked to certain autoimmune syndromes, and by potentially modulating the immune response through the management of fungal infections in patients with autoimmune conditions. For instance, in March 2023, according to the National Institutes of Health, a US-based federal agency for conducting and supporting medical research, an estimated 8.4 million people globally were predicted to have type 1 diabetes (T1DM) in 2021, with 500,000 new cases reported in that year. Further, the estimated population with T1DM is expected to be between 13.5 and 17.4 million by 2040. Therefore, the rise in the prevalence of autoimmune diseases is driving the growth of the yeast infection treatment market.

Key Industry Players

Major companies operating in the yeast infection treatment market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi SA, Thermo Fisher Scientific Inc., Abbott Laboratories, AstraZeneca PLC, Bayer AG, Astellas Pharma Inc., Torrent Pharmaceuticals, Catalent Inc., bioMérieux SA, Cipla, Bruker Corporation, Brundavan Laboratories Private Limited, Glenmark Pharmaceuticals Ltd, Zydus Lifesciences, Prestige Consumer Healthcare Inc., CordenPharma International, Synmedic Laboratories, Basilea Pharmaceutica AG, Jubilant Pharmova Limited, Curia Global Inc., Synexis LLC, Manus Aktteva Biopharma LLP

The yeast infection treatment market report table of contents includes:

1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis

………

27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

collect
0
avatar
rama
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more